JGL in third phase of clinical trial of innovative cold spray

The Jadran-Galenski laboratorij (JGL) pharmaceutical company is conducting the third phase of a multinational clinical trial of an innovative nasal spray for the cold, in which almost 500 patients from Germany, Poland, Bulgaria and Croatia will participate, the company reported on Monday. Pročitaj više